Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes fromFinra
Moving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.
Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
Generic-drug maker Viatris initiated a dividend on Monday, but VTRS stock plummeted after the company issued a downbeat 2021 outlook. Viatris is a combination of Pfizer's Upjohn and Mylan.
Shares of Viatris Inc. tumbled 11.0% in premarket trading, to pace all of the S&P 500's decliners ahead of the open, after the pharmaceutical and health care services company provided a downbeat 2021 revenue outlook, while saying it was initiating a dividend. The company, formed in November through the combination of Mylan and Pfizer Inc.'s Upjohn business, said it expects 2021 revenue of $17.2 billion to $17.8 billion, compared with the FactSet consensus of $18.36 billion. Free cash flow is exp...
Viatris Inc. (NASDAQ: VTRS) today announced its 2021 financial guidance and reaffirmed its commitment to rapid de-leveraging, to enhancing and growing free cash flows, particularly following the phasing out of one-time and other stand up costs, to initiating a dividend, and to delivering total shareholder return (TSR).
announced today that Health Canada has approved Hulio®i, and product is now available in Canada. Hulio® is a biosimilar to AbbVie's Humira®ii (adalimumab).
In this article, we discussed billionaire Ken Fisher’s 10 new stock picks to see how these stocks performed so far in 2021. Click to skip ahead and see Billionaire Ken Fisher’s 5 New Stock Picks. Kenneth Fisher is an American billionaire and hedge fund manager. His total worth stands at $4.3 billion. In a latest […]
Viatris Inc. (NASDAQ: VTRS) today announced that it will host a conference call at 8 a.m. ET on Monday, Feb. 22 to discuss 2021 financial guidance.
Pfizer said Tuesday it expects $15 billion in sales of its BioNTech-partnered Covid-19 vaccine this year. But Pfizer stock tumbled on lighter-than-expected fourth-quarter earnings.